Biome Commences Test Market in Canada
Biome Australia’s Founder and Managing Director, Blair Vega Norfolk, commented: “I am excited to announce this new partnership with Ecotrend… Read more
Biome Q1 FY25 Revenue Guidance
Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the company’) is pleased to announce, after a strong start… Read more
Biome Investor Webinar Recording
Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the company’) is pleased to provide access to the recording… Read more
Biome Investor Presentation
Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven condition-specific probiotic… Read more
Biome FY24 Financial Update
Biome Australia Limited (ASX: BIO) has provided an update on the financial year 2024. Notable Highlights: The company achieved an… Read more
Biome’s Clinically Proven Cholesterol Reducing Probiotic Launched
Biome’s Clinically Proven Cholesterol Reducing Probiotic Launched: ● Biome has launched its new cholesterol lowering probiotic, Biome Cholesterol Probiotic, in… Read more
Biome shares revenue target as part of Vision 27 Strategic Plan
Biome Australia Limited (ASX:BIO) has released a cumulative revenue target for the next three years from FY2025 and FY2027 of… Read more
Biome Australia Quarterly Activities & Appendix 4C June 2024
Biome has released their Quarterly for June 24. It is once again an outstanding report and continues to underline why… Read more
Biome Achieves Record Quarter, Half and Full-Year Sales Revenue (unaudited)
● Biome records ○ ~$13m FY24 sales revenue, up 80% vs PCP ○ ~$7m H2 FY24 sales revenue, up 82%… Read more